These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 25427739

  • 1. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
    Yoon HI, Seong J.
    Oncology; 2014; 87 Suppl 1():90-8. PubMed ID: 25427739
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Management of hepatocellular carcinoma -- experience of a single center.
    Iliescu L, Mindrut E, Grasu M, Orban C, Tanase A, Toma L.
    Chirurgia (Bucur); 2014; 109(2):204-7. PubMed ID: 24742411
    [Abstract] [Full Text] [Related]

  • 4. Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.
    Han HJ, Kim MS, Cha J, Choi JS, Han KH, Seong J.
    Oncology; 2014; 87 Suppl 1():82-9. PubMed ID: 25427738
    [Abstract] [Full Text] [Related]

  • 5. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma.
    Cho JY, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    Liver Int; 2014 May; 34(5):795-801. PubMed ID: 24350564
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma.
    Yoon HI, Jung I, Han KH, Seong J.
    Oncotarget; 2016 Sep 20; 7(38):62715-62725. PubMed ID: 27486881
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of hepatocellular carcinoma: beyond international guidelines.
    Sangiovanni A, Colombo M.
    Liver Int; 2016 Jan 20; 36 Suppl 1():124-9. PubMed ID: 26725909
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
    Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M.
    J Hepatol; 2012 Apr 20; 56(4):886-92. PubMed ID: 22173160
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma.
    Chen SW, Lin LC, Kuo YC, Liang JA, Kuo CC, Chiou JF.
    Int J Radiat Oncol Biol Phys; 2014 Apr 01; 88(5):1041-7. PubMed ID: 24661657
    [Abstract] [Full Text] [Related]

  • 20. Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.
    Ramanathan R, Sharma A, Lee DD, Behnke M, Bornstein K, Stravitz RT, Sydnor M, Fulcher A, Cotterell A, Posner MP, Fisher RA.
    Transplantation; 2014 Jul 15; 98(1):100-6. PubMed ID: 24503764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.